Acute-Onset Dystonia Following Ashwagandha Supplementation (Withania somnifera): A Case Report
Misbah Fazlani1, Pushparaja Shetty2, Ahmer Longi1
1Internal Medicine, Mediclinic Welcare Hospital, Dubai, ARE.
Abstract:
Ashwagandha (Withania somnifera) is a widely used herbal supplement with established adaptogenic and neuroprotective properties. Although generally considered safe, rare adverse neurological effects may occur. We present the case of a previously healthy adult male who developed acute-onset dystonia following the initiation of Ashwagandha supplementation. The patient exhibited sustained involuntary muscle contractions and abnormal posturing shortly after commencing the supplement. Extensive diagnostic evaluation failed to identify an alternative etiology. Discontinuation of Ashwagandha and initiation of symptomatic treatment led to the resolution of symptoms. This case underscores the importance of considering herbal supplements as potential contributors to neurological presentations.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...


